LOGIN  |  REGISTER
Astria Therapeutics

Recent Insider Transactions - Regeneron Pharmaceuticals (NASDAQ: REGN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ REGN Regeneron Pharmaceuticals
Van Plew Daniel P / officer: EVP & General Mgr, Industrial
12/16/2024
Sell
$730.81
969
$708K
34,792
NASDAQ REGN Regeneron Pharmaceuticals
STAHL NEIL / officer: EVP Research and Development
12/16/2024
Sell
$730.81
304
$222K
48,829
NASDAQ REGN Regeneron Pharmaceuticals
Pitofsky Jason / officer: VP Controller
12/16/2024
Sell
$730.81
298
$218K
4,664
NASDAQ REGN Regeneron Pharmaceuticals
MURPHY ANDREW J / officer: EVP Research
12/16/2024
Sell
$730.81
1,054
$770K
49,074
NASDAQ REGN Regeneron Pharmaceuticals
McCourt Marion / officer: EVP Commercial
12/16/2024
Sell
$730.81
759
$555K
14,230
NASDAQ REGN Regeneron Pharmaceuticals
LAROSA JOSEPH J / officer: EVP General Counsel and Secret
12/16/2024
Sell
$730.81
702
$513K
30,075
NASDAQ REGN Regeneron Pharmaceuticals
Fenimore Christopher R. / officer: SVP Finance & CFO
12/16/2024
Sell
$730.81
491
$359K
16,265
NASDAQ REGN Regeneron Pharmaceuticals
Pitofsky Jason / officer: VP Controller
12/09/2024
Sell
$787.00
149
$117K
4,962
NASDAQ REGN Regeneron Pharmaceuticals
Pitofsky Jason / officer: VP Controller
12/06/2024
Buy
$771.64
3,236
$2.497M
3,236
NASDAQ REGN Regeneron Pharmaceuticals
Fenimore Christopher R. / officer: SVP Finance & CFO
12/09/2024
Sell
$787.00
1,140
$897K
16,756
NASDAQ REGN Regeneron Pharmaceuticals
Fenimore Christopher R. / officer: SVP Finance & CFO
12/06/2024
Buy
$771.64
9,979
$7.700M
9,979
NASDAQ REGN Regeneron Pharmaceuticals
STAHL NEIL / officer: EVP Research and Development
12/09/2024
Sell
$787.00
466
$367K
49,133
NASDAQ REGN Regeneron Pharmaceuticals
Van Plew Daniel P / officer: EVP & General Mgr, Industrial
12/09/2024
Sell
$787.00
492
$387K
35,761
NASDAQ REGN Regeneron Pharmaceuticals
Van Plew Daniel P / officer: EVP & General Mgr, Industrial
12/06/2024
Buy
$771.64
13,472
$10.396M
13,472
NASDAQ REGN Regeneron Pharmaceuticals
MURPHY ANDREW J / officer: EVP Research
12/09/2024
Sell
$787.00
492
$387K
50,128
NASDAQ REGN Regeneron Pharmaceuticals
MURPHY ANDREW J / officer: EVP Research
12/06/2024
Buy
$771.64
13,472
$10.396M
13,472
NASDAQ REGN Regeneron Pharmaceuticals
McCourt Marion / officer: EVP Commercial
12/09/2024
Sell
$787.00
274
$216K
14,989
NASDAQ REGN Regeneron Pharmaceuticals
McCourt Marion / officer: EVP Commercial
12/06/2024
Buy
$771.64
8,981
$6.930M
8,981
NASDAQ REGN Regeneron Pharmaceuticals
LAROSA JOSEPH J / officer: EVP General Counsel and Secret
12/09/2024
Sell
$787.00
492
$387K
30,777
NASDAQ REGN Regeneron Pharmaceuticals
LAROSA JOSEPH J / officer: EVP General Counsel and Secret
12/06/2024
Buy
$771.64
8,981
$6.930M
8,981
NASDAQ REGN Regeneron Pharmaceuticals
McCourt Marion / officer: EVP Commercial
11/01/2024
Buy
$381.40
1,000
$381K
13,931
NASDAQ REGN Regeneron Pharmaceuticals
McCourt Marion / officer: EVP Commercial
11/01/2024
Sell
$844.61
1,000
$845K
12,931
NASDAQ REGN Regeneron Pharmaceuticals
McCourt Marion / officer: EVP Commercial
11/01/2024
Sell
$381.40
1,000
$381K
6,000

COPYRIGHT ©2023 HEALTH STOCKS HUB